Heidelberg Pharma ( ETR:HPHA ) First Quarter 2024 Results Key Financial Results Revenue: €1.86m (down 10% from 1Q...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment. RHB-107 (upamostat) is the first drug being tested in this platform study. Funded through non-dilutive external sources, including the U.S. Department of D
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term...